*Non-invasive phenotyping of molecular brain tumour profiles using novel advanced MR imaging and analysis'

*Non-invasive phenotyping of molecular brain tumour profiles using novel advanced MR imaging and analysis' - *Brain tumour radiogenomics*

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON47240

Enrollment

300

Registered

2018-06-12

Start date

2016-12-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain tumour

Interventions

Brain tumour

Molecular profiles

MR imaging

Phenotyping

Eligibility

Age

18 Years to 64 Years

Inclusion criteria

Inclusion criteria: - Individuals of 18 years or older - Referred for surgery (resection or biopsy) of a primary brain tumour - Written informed consent

Exclusion criteria

Exclusion criteria: - Contra-indication for MRI (implanted metal parts, e.g. stents, vascular clips, pacemakers) - Inability to give consent

Design outcomes

Primary

Measure	Time frame
Diagnostic accuracy (true / false positive / negative) in identification of Class 3 patients using structural and physiological MRI.	—

Countries

The Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)